Key Metrics for Recent Technology and Life Sciences Initial Public Offerings


In This Survey:

- Survey Results

- Offerings Completed

- Size of Offering 2013, First Half

- Size of Offering 2011-2012

- Aggregate Amount Raised 2013, First Half

- Aggregate Amount Raised 2011-2012

- Price Changes Between the Red Herring and Initial Offering

- Price Changes Around the Expiration of the Lock Up

- List of Offerings: First Half 2013

- Methodology

- Excerpt from Survey Results:

The first half of 2013 culminated with Q2 representing the strongest quarter for technology and life sciences IPOs in more than 10 quarters. The life sciences sector was especially active, with 18 offerings in the first half of the year. Life sciences IPOs were at the top end of the scale in terms of size of the offering. Zoetis, a wholly owned subsidiary of Pfizer, raised more than $2.2 billion and Quintiles Transnational raised more than $900 million. Life sciences IPOs were also at the lower end in terms of size, with three offerings each raising less than $50 million. The largest technology offering, Tableau Software, raised $250 million.

Please see full Survey below for more information.

LOADING PDF: If there are any problems, click here to download the file.

Written by:

Published In:


DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© Fenwick & West LLP | Attorney Advertising

Don't miss a thing! Build a custom news brief:

Read fresh new writing on compliance, cybersecurity, Dodd-Frank, whistleblowers, social media, hiring & firing, patent reform, the NLRB, Obamacare, the SEC…

…or whatever matters the most to you. Follow authors, firms, and topics on JD Supra.

Create your news brief now - it's free and easy »

All the intelligence you need, in one easy email:

Great! Your first step to building an email digest of JD Supra authors and topics. Log in with LinkedIn so we can start sending your digest...

Sign up for your custom alerts now, using LinkedIn ›

* With LinkedIn, you don't need to create a separate login to manage your free JD Supra account, and we can make suggestions based on your needs and interests. We will not post anything on LinkedIn in your name.